73 related articles for article (PubMed ID: 578759)
41. Spironolactone metabolism and gynaecomastia.
Overdiek JW; Merkus FW
Lancet; 1986 May; 1(8489):1103. PubMed ID: 2871374
[No Abstract] [Full Text] [Related]
42. ADMINISTRATION OF SPIRONOLACTONE AS A SOURCE OF ERROR IN DETERMINATION OF 17-KETOSTEROIDS IN URINE.
LYNGBYE J; JOHNSEN SG
Scand J Clin Lab Invest; 1964; 16():427-32. PubMed ID: 14204683
[No Abstract] [Full Text] [Related]
43. Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man.
Abshagen U; von Grodzicki U; Hirschberger U; Rennekamp H
Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):281-7. PubMed ID: 600314
[No Abstract] [Full Text] [Related]
44. Microbial synthesis of mammalian metabolites of spironolactone by thermophilic fungus Thermomyces lanuginosus.
B S; G S; V KR; S G
Steroids; 2018 Aug; 136():1-7. PubMed ID: 29803817
[TBL] [Abstract][Full Text] [Related]
45. Limitations of the MANOVA of statistical moments in bioequivalence trials of drugs with slow elimination rate: a study with spironolactone.
Concheiro A; Llabres M; Martinez R; Vila JL
Biopharm Drug Dispos; 1986; 7(3):253-64. PubMed ID: 3730525
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of miocamycin in patients with liver cirrhosis.
Miglioli PA; Pivetta P; Orlando R; Palatini P; Varotto A; Okolicsanyi L
Chemotherapy; 1989; 35(5):330-2. PubMed ID: 2791710
[TBL] [Abstract][Full Text] [Related]
47. Disposition of tritium-labeled spirolactones in the dog.
Sadée W; Riegelman S; Jones SC
J Pharm Sci; 1972 Jul; 61(7):1132-5. PubMed ID: 5044816
[No Abstract] [Full Text] [Related]
48. Preparation of metabolites of spironolactone by microbial oxygenation.
Marsheck WJ; Karim A
Appl Microbiol; 1973 Apr; 25(4):647-9. PubMed ID: 4699222
[TBL] [Abstract][Full Text] [Related]
49. The influence of spironolactone on its own biotransformation.
Solymoss B; Tóth S; Varga S; Krajny M
Steroids; 1970 Sep; 16(3):263-75. PubMed ID: 5495612
[No Abstract] [Full Text] [Related]
50. The active constituent of spironolactone after acute administration in man [proceedings].
McInnes GT; Asbury MJ; Shelton JR; Harrison IR; Ramsay LE; Venning GR; Clarke JM
Br J Clin Pharmacol; 1980 Mar; 9(3):295P-296P. PubMed ID: 7362751
[No Abstract] [Full Text] [Related]
51. Influence on application and dosis on the effect of aldadiene-K on the rat brain.
Platt D; Luboeinski MP; Norwig P; Dieker P
Klin Wochenschr; 1972 Oct; 50(20):977-8. PubMed ID: 5080067
[No Abstract] [Full Text] [Related]
52. Spironolactone and plasma cortisol.
Dumlao JS; Kannan C; Krauss T; Brooks MH
Clin Pharmacol Ther; 1973; 14(6):992-4. PubMed ID: 4584157
[No Abstract] [Full Text] [Related]
53. [Treatment of cirrhotic edema].
VESIN P; CATTAN R
Vie Med; 1962 Dec; 43():1767-71. PubMed ID: 13996950
[No Abstract] [Full Text] [Related]
54. Metabolic studies on the effects of sprinolacton.
JICK H; MORRISON RS; MOORE EW; CHALMERS TC
Metabolism; 1963 May; 12():381-7. PubMed ID: 13957747
[No Abstract] [Full Text] [Related]
55. Spironolactone.
Br Med J; 1967 Jun; 2(5554):751. PubMed ID: 6025984
[No Abstract] [Full Text] [Related]
56. Mineral metabolism: Spironolactone and calcification.
Carney EF
Nat Rev Nephrol; 2013 Mar; 9(3):125. PubMed ID: 23358423
[No Abstract] [Full Text] [Related]
57. Guide to drug dosage in hepatic disease.
Bass NM; Williams RL
Clin Pharmacokinet; 1988 Dec; 15(6):396-420. PubMed ID: 3072141
[No Abstract] [Full Text] [Related]
58. Improved bioavailability from a spironolactone beta-cyclodextrin complex.
Yusuff NT; York P; Chrystyn H; Bramley PN; Swallow RD; Tuladhar BR; Losowsky MS
Eur J Clin Pharmacol; 1991; 40(5):507-11. PubMed ID: 1884726
[TBL] [Abstract][Full Text] [Related]
59. Spironolactone metabolism in normal subjects and in patients with liver cirrhosis.
Váradi A; Fehér T; Bodrogi L; Koref O
Arzneimittelforschung; 1977; 27(8):1618-20. PubMed ID: 578759
[TBL] [Abstract][Full Text] [Related]
60. Metabolism of a prednisolone compound in human under normal and pathological conditions.
Fehér T; Koref O; Tankó A; Bodrogi L; Poteczin E
Arzneimittelforschung; 1975 Aug; 25(8):1314-7. PubMed ID: 52365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
